GLXY compared with TAK: revenue, margins and what each company keeps, and the suppliers and customers both name

GLXYGalaxy Digital Inc.

Mkt capRevenueRevenue

TAKTakeda Pharmaceutical Co Ltd

Mkt capRevenueRevenue

Compare

GLXYGalaxy Digital Inc.

TAKTakeda Pharmaceutical Co Ltd

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

GLXY, solidTAK, dashed

Supply-chain overlap

Revenue flow

GLXY: latest quarter is a loss; flow not drawable. TAK: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only GLXY 16

MSFTMicrosoft Azuresupplier

AMZNAmazon Web Servicessupplier

CRWVCoreWeavecustomer

SLNHSolunasupplier

12 more · GLXY chain ›

Shared 0

No shared counterparties.

Only TAK 17

NBIXNeurocrine Biosciencescustomer

EXELExelixissupplier

PTGXProtagonist Therapeuticssupplier

DNLIDenali Therapeuticssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

13 more · TAK chain ›

GLXYGalaxy Digital Inc.

15.97▼−11.92%· post 16.03

Mkt cap$3.1BRevenue$8.7BQ2 FY26Revenue$74.2BFY25

TAKTakeda Pharmaceutical Co Ltd

20.92▲+4.55%· post 20.93

ClosedOct 30 '26

Mkt cap$36.0BRevenue—Revenue—

Compare

ClosedOct 30 '26

GLXYGalaxy Digital Inc.

TAKTakeda Pharmaceutical Co Ltd

15.97▼−11.92%post 16.03

Price

20.92▲+4.55%post 20.93

$3.1B

Mkt cap

$36.0B

Q2 FY26$8.7B

Revenue

—

FY25$74.2B

Revenue

—

GLXY15.97▼−11.92%vsTAK20.92▲+4.55%ClosedOct 30 '26